Exacerbated metastatic disease in a mouse mammary tumor model following latent gammaherpesvirus infection
Open Access
- 29 May 2012
- journal article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 7 (1) , 11
Abstract
Background: Controversy exists as to the ability of human gammaherpesviruses to cause or exacerbate breast cancer disease in patients. The difficulty in conducting definitive human studies can be over come by investigating developing breast cancer in a mouse model. In this study, we utilized mice latently infected with murine gammaherpesvirus 68 (HV-68) to question whether such a viral burden could exacerbate metastatic breast cancer disease using a mouse mammary tumor model.Results: Mice latently infected with HV-68 had a similar primary tumor burden, but much greater metastatic disease, when compared to mock treated mice given the transplantable tumor, 4 T1. This was true for lung lesions, as well as secondary tumor masses. Increased expression of pan-cytokeratin and VEGF-A in tumors from HV-68 infected mice was consistent with increased metastatic disease in these animals. Surprisingly, no viral particles could be cultured from tumor tissues, and the presence of viral DNA or RNA transcripts could not be detected in primary or secondary tumor tissues.Conclusions: Latent HV-68 infection had no significant effect on the size of primary 4 T1 mammary tumors, but exacerbated the number of metastatic lung lesions and secondary tumors when compared to mock treated mice. Increased expression of the tumor marker, pan-cytokeratin, and VEGF-A in tumors of mice harboring latent virus was consistent with an exacerbated metastatic disease. Mechanisms responsible for this exacerbation are indirect, since no virus could be detected in cancerous tissues.Keywords
This publication has 55 references indexed in Scilit:
- 3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infectionDrug and Alcohol Dependence, 2011
- Epstein-Barr virus as a marker of biological aggressiveness in breast cancerBritish Journal of Cancer, 2010
- Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast CarcinomaPLOS ONE, 2010
- Epstein‐Barr virus and gastric carcinomaPathology International, 2010
- Breast cancer, cytomegalovirus and Epstein–Barr virus: a nested case–control studyBritish Journal of Cancer, 2010
- Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative DisorderClinical Microbiology Reviews, 2010
- Association of Epstein Barr Virus Infection (EBV) with Breast Cancer in Rural Indian WomenPLOS ONE, 2009
- Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritisBreast Cancer Research, 2009
- Immune escape by Epstein–Barr virus associated malignanciesSeminars in Cancer Biology, 2008
- Expression of Neuronal Trace Amine-associated Receptor (Taar) mRNAs in LeukocytesJournal of Neuroimmunology, 2007